Quantcast

Baltimore-based Cerecor announces deal with Merck (access required)

Posted: 2:00 pm Wed, March 20, 2013
By Daily Record Staff

Cerecor Inc., of Baltimore, a development-stage biotechnology company, said it has agreed to acquire potential treatments for Parkinson's disease and other central nervous system disorders from Merck & Co.

Comments

Comments are closed.

Copyright © 2012, Maryland Daily Record 11 E. Saratoga Street, Baltimore, MD, 21202 · Tel: 443-524-8100